Corvus Pharmaceuticals 代幣化股票價格

Corvus Pharmaceuticals is the name of the stock, typically based on the name of the company or ETF.

CRVS is the ticker symbol for Corvus Pharmaceuticals on a stock exchange and represents the underlying stock. It can be traded on traditional stock exchanges such as Nasdaq or the NYSE during applicable exchange trading hours, typically in fiat currency such as USD. Holders of CRVS shares may receive dividends and have shareholder status and voting rights in the company.

Corvus Pharmaceuticals tokenized stock is a new type of stock asset that brings CRVS stock on-chain and represents a tokenized form of CRVS stock. Corvus Pharmaceuticals tokenized stock can be traded on crypto exchanges. The name of Corvus Pharmaceuticals tokenized stock may vary by issuer, but all versions track the price and other relevant attributes of CRVS stock.

RWA issuance platform Reality has launched a series of tokenized products backed 1:1 by real stocks, collectively known as Bitget rToken. Bitget rToken supports 24/7 trading on the Bitget exchange and is typically priced and traded using stablecoins such as USDT. As one of the most popular tokenized stock products in the global market, Bitget rToken allows holders to receive dividend distributions corresponding to those of the underlying stock, automatically paid in USDT. However, holders do not have legal shareholder status or voting rights in the company.

rCRVS is the rToken code for the Corvus Pharmaceuticals tokenized stock issued by Reality. On the Bitget crypto exchange, rCRVS is available for spot trading through the rCRVS/USDT trading pair.

Bitget was among the first crypto exchanges to support trading Corvus Pharmaceuticals stock. There are currently two main ways to trade Corvus Pharmaceuticals stock on Bitget:

1. Buy Bitget rToken: Trade rCRVS on Bitget's spot stock market using stablecoins such as USDT. rCRVS is an RWA token for Corvus Pharmaceuticals, based on Corvus Pharmaceuticals stock.

2. Buy through Bitget Stock+: Use stablecoins such as USDT to directly purchase real Corvus Pharmaceuticals shares (CRVS) on the U.S. stock market.

View all Bitget rToken products

Reality is the RWA issuance platform behind rToken, strategically backed by Bitget. It connects rToken to the underlying U.S. securities through regulated brokerage, custody, settlement, and blockchain infrastructure. Reality also engages U.S.-registered accounting firm The Network Firm to publish daily Proof of Reserves reports, verifying the 1:1 correspondence between issued rTokens and the underlying holdings.

Reality's official website: https://realityfinance.xyz

rCRVS is deployed on the Arbitrum network. Users can view detailed issuance information for rCRVS on the rCRVS token details page on Reality's official website (https://realityfinance.xyz/en/market/detail/CRVS). Users can also use the rCRVS token contract address to look up information such as the issuer (Reality) identifier for rCRVS and its Proof of Reserves records on an Arbitrum blockchain explorer.

The CRVS tokenized stock issued by Reality is rCRVS, an RWA crypto token that tracks real Corvus Pharmaceuticals stock on a 1:1 basis through blockchain technology and is supported for trading by Bitget.

Key features include:

1. Price tracking and economic benefits: Its price movements track Corvus Pharmaceuticals stock (CRVS) in the U.S. market in real time, and holders can receive dividends automatically distributed in USDT.

2. Crypto asset flexibility: It can be purchased directly using stablecoins such as USDT and supports fractional trading starting from as little as 1 USDT.

3. 24/7 trading and multiple uses: It supports 24/7 trading and can also be used directly as margin for futures trading or as collateral on crypto exchanges such as Bitget.

Bitget users can buy rCRVS on Bitget's spot stock market through the rCRVS/USDT trading pair.

Yes. rCRVS is a real-world asset (RWA) token issued by the licensed issuer Reality and supported for trading by Bitget.

Here's why:

1. Backed by a real underlying asset: rCRVS is not a purely synthetic crypto asset. It is issued by the licensed RWA protocol Reality, with each rCRVS backed 1:1 by real Corvus Pharmaceuticals shares (CRVS) held in custody with a compliant U.S. broker.

2. Tokenized on-chain: It tokenizes real-world stock assets from traditional finance (TradFi), allowing them to be transferred, traded, and settled in token form on the blockchain or through the crypto exchange Bitget.

3. Exposure to real economic benefits: Holders can benefit from changes in the underlying stock price and receive dividends generated by the underlying shares, which are automatically distributed in USDT. This reflects a key characteristic of RWA assets: linking on-chain tokens to real-world cash flows and economic rights.

rCRVS is a Corvus Pharmaceuticals tokenized stock issued by the licensed RWA protocol Reality. It is backed 1:1 by real Corvus Pharmaceuticals stock (CRVS) and can be traded on the crypto exchange Bitget through the rCRVS/USDT trading pair. Its pricing and operating mechanisms are as follows:

Price formation and tracking

Real-time price tracking: The price of rCRVS tracks Corvus Pharmaceuticals stock (CRVS) listed on the U.S. stock market on a 1:1 basis.

Direct access to native liquidity (during U.S. market hours): During regular, pre-market, and post-market trading sessions in the U.S. stock market, rCRVS spot orders are routed directly through the system to the Nasdaq or NYSE order book for execution, resulting in zero spread and eliminating depegging risk.

On-exchange pricing (when U.S. markets are closed or on weekends): When the U.S. stock market is closed, rCRVS switches to 24/7 on-exchange trading. Its price is generally based on the most recent U.S. stock market closing price and fluctuates dynamically based on buy and sell orders matched on the crypto exchange.

Underlying asset and economic rights

1:1 backing by real assets: Each rCRVS token issued is backed 1:1 by real shares of Corvus Pharmaceuticals held in custody with a compliant U.S. broker such as Alpaca. The reserves are also subject to daily Proof of Reserves (PoR) verification using Merkle tree data.

Minting and burning: When a user or institution subscribes to rCRVS on the platform, Reality purchases the corresponding amount of Corvus Pharmaceuticals stock in the U.S. market and mints new tokens. Upon redemption, the tokens are burned and the corresponding stock reserves are released.

Automatic dividend distribution and stock split handling:

Dividend payouts: When Corvus Pharmaceuticals stock pays a dividend in USD, a 30% U.S. withholding tax is automatically deducted. The remaining net dividend is converted to USDT and distributed to users' crypto accounts in proportion to their holdings.

Stock splits and reverse splits: In the event of a stock split, reverse split, or other corporate action, the system automatically adjusts the amount of rCRVS in users' accounts proportionally, with no manual action required.

Crypto utility and unified trading account use: rCRVS has the flexibility of a crypto asset. In addition to 24/7 trading, it can be used directly as margin for futures trading or as collateral for crypto borrowing in the unified trading account (UTA).

CRVS is the underlying Corvus Pharmaceuticals stock, while rCRVS is the Corvus Pharmaceuticals tokenized stock issued by Reality and supported for trading by Bitget, backed 1:1 by CRVS stock. rCRVS brings CRVS stock on-chain.

Here's how the two are related and how they differ:

1:1 backing: rCRVS is issued by Reality, with each rCRVS backed by one real share of CRVS held in reserve. As a result, rCRVS's market performance and price movements track those of the underlying CRVS stock.

Economic benefits (dividends and stock splits): Holding rCRVS provides economic benefits corresponding to those of the underlying stock. For example, when CRVS pays a dividend, rCRVS holders receive a proportional dividend distribution converted to USDT in their accounts. Adjustments for stock splits and reverse splits are also reflected accordingly.

Legal status and trading access:

CRVS: Holders directly own shares in a publicly listed company through a traditional securities broker, with their equity interests subject to regulation by the SEC (U.S. Securities and Exchange Commission).

rCRVS: An RWA crypto token issued on the blockchain. It does not confer direct shareholder status or voting rights in Corvus Pharmaceuticals, but provides corresponding economic exposure to the underlying asset.

Trading flexibility:

CRVS is generally traded in whole or fractional shares through a traditional broker during available U.S. stock market trading sessions, using fiat currency such as USD.

rCRVS can be traded 24/7 on the crypto exchange Bitget using stablecoins such as USDT. It supports flexible fractional trading and can also be used as collateral or margin for crypto derivatives trading.

Although rCRVS tracks the price movements and dividend returns of CRVS stock on a 1:1 basis, the two differ significantly in their underlying structure and use cases:

1. Asset structure and legal status

CRVS: Represents equity in a publicly listed company. Holders are registered shareholders of the company and have voting rights at shareholder meetings. The stock is regulated by financial authorities and organizations such as the SEC (U.S. Securities and Exchange Commission) and FINRA (Financial Industry Regulatory Authority), while eligible brokerage accounts may also be protected by SIPC (Securities Investor Protection Corporation).

rCRVS: An RWA crypto token issued on-chain by Reality and supported for trading by Bitget. Holders receive economic exposure corresponding to that of the underlying shares but do not directly own shares in Corvus Pharmaceuticals or have shareholder voting rights.

2. Trading hours and settlement

CRVS: Trading is limited to U.S. stock market trading sessions, including regular trading hours from 9:30 AM to 4:00 PM ET as well as available pre-market and after-hours sessions. Trades are settled in U.S. dollars, and fund movements are subject to the clearing and settlement cycles of the traditional financial system.

rCRVS: Tradable 24/7 using stablecoins such as USDT, with funds credited within seconds and no need to wait for currency conversion or traditional settlement.

3. Accessibility and fractional trading

CRVS: Typically requires opening an account with a traditional broker and completing identity and address verification.

rCRVS: Offers a simpler account-opening and identity verification process, with fractional purchases starting from as little as 1 USDT, lowering the barrier to entry.

4. Crypto utility and capital efficiency

CRVS: A traditional financial asset that cannot directly participate in the blockchain ecosystem or crypto trading.

rCRVS: Has the flexibility of a crypto token. In addition to spot trading, it can be transferred directly, used as margin in a unified trading account on a crypto exchange such as Bitget, or used as collateral to borrow crypto assets, enabling highly efficient capital use.

Holding rCRVS does not make you a direct shareholder and does not grant voting rights. rCRVS is a tokenized asset issued by Reality and supported for trading by Bitget, rather than direct equity in the company.

No direct shareholder status: rCRVS is essentially an RWA (real-world asset) token issued on-chain by Reality and backed by real shares held in custody. The underlying Corvus Pharmaceuticals shares are held in custody with a compliant broker under the issuer's name, so you are not directly registered as a shareholder of Corvus Pharmaceuticals.

No voting rights at shareholder meetings: Because you are not a registered shareholder, you cannot participate in Corvus Pharmaceuticals's shareholder meetings or vote on major corporate matters, such as board elections or major acquisition proposals.

Economic benefits only: Although you do not have voting rights, you can still receive the economic benefits associated with the underlying stock, including gains from changes in its market price and USDT dividend distributions based on your holdings when Corvus Pharmaceuticals pays a dividend.

No. They are two completely separate products and should not be confused with each other.

rCRVS/USDT on the spot market: The spot trading pair for rCRVS, the RWA token based on CRVS stock. rCRVS is issued by Reality and supported for trading by Bitget. It is a tokenized stock asset backed 1:1 by real Corvus Pharmaceuticals shares (CRVS), and holders are entitled to the corresponding economic benefits of the underlying stock, including dividends and adjustments for stock splits.

CRVSUSDT on the futures market: A futures derivative linked to CRVS stock. The CRVSUSDT perpetual futures contract is a separate derivative offered by Bitget for trading the price movements of Corvus Pharmaceuticals stock. It does not represent ownership of the underlying stock or confer dividend rights, and it is not linked to Reality's Proof of Reserves mechanism.

Simply put, rCRVS is a tokenized representation of the stock, while CRVSUSDT perpetual futures contract is a derivative linked to the stock. The two differ in their risk structures, economic rights, and funding rate mechanisms, so users should clearly distinguish between them when choosing what to trade.

When Corvus Pharmaceuticals undergoes a stock split or reverse stock split, the quantity and price of rCRVS, issued by Reality and supported for trading by Bitget, are automatically adjusted accordingly, while the total value of each user's rCRVS holdings remains unchanged.

The adjustment mechanism and process are as follows:

Holdings and unit price are adjusted proportionally:

Stock split example (e.g., 10-for-1): If you hold 1 rCRVS, once the stock split takes effect, your rCRVS balance automatically increases to 10, while the unit price of rCRVS is adjusted to one-tenth of its previous price. Your total position value remains unchanged.

Reverse stock split example (e.g., 1-for-10): If you hold 10 rCRVS, once the reverse stock split takes effect, your rCRVS balance automatically decreases to 1, while the unit price of rCRVS is adjusted to 10 times its previous price. Your total position value remains unchanged.

Fully automatic, with no action required: Once the underlying U.S. shares held in custody by Reality complete the stock split or reverse stock split at the clearing level, the platform automatically updates users' on-chain and account holdings in the background. No manual withdrawal, conversion, or other action is required.

Temporary trading suspension and order cancellation: During the clearing window when a stock split or reverse stock split takes effect, the platform typically suspends trading of rCRVS and automatically cancels unfilled orders. Trading resumes automatically once account reconciliation and token quantity adjustments are complete.

Automatic adjustment of futures margin and collateral: If rCRVS is used as margin for futures trading or pledged as collateral for borrowing, the system automatically adjusts the collateral quantity and index mark price based on the stock split or reverse stock split ratio, helping ensure that your leverage and margin health are not affected by the change in quantity.

rCRVS is issued by Reality and supported for trading by Bitget, with 24/7 trading available. You can continue to buy and sell rCRVS when U.S. markets are closed or on weekends, with different pricing mechanisms applying during different trading periods.

U.S. market closures and weekend trading: rCRVS is tradable 24/7

During U.S. market hours (including pre-market, regular, and after-hours sessions): rCRVS orders are routed directly to the Nasdaq or NYSE order book, with prices synchronized in real time with the underlying U.S. stock market.

When U.S. markets are closed or on weekends: The system switches to on-exchange crypto market trading. Users can continue to place orders and trade using USDT on the exchange at any time.

rCRVS does not depeg

When U.S. markets are open (no depegging): Orders are routed directly to the U.S. stock market for execution, and execution prices track current U.S. stock prices directly, so depegging does not occur.

When U.S. markets are closed or on weekends (market-driven pricing rather than depegging):

While the U.S. stock market is closed and no new stock prices are being quoted, the price of rCRVS on the crypto exchange is determined by buy and sell orders matched on the exchange.

If major news breaks over the weekend, such as policy changes or significant industry developments, rCRVS may rise or fall in advance as market sentiment is reflected in its price. This represents early price discovery in the crypto market outside U.S. trading hours. When the U.S. stock market reopens on Monday, the price can quickly realign with the underlying stock market through the live order book.

Weekend trading risk notice

Lower liquidity than usual: With no native U.S. stock market liquidity during market closures, the order book may be thinner, and larger trades may face slightly wider bid-ask spreads.

Liquidation protection when used as futures margin: If rCRVS is used as margin for futures trading, the platform typically uses Friday's U.S. stock market closing price as a fixed index mark price over the weekend for risk calculations, helping prevent small on-exchange price fluctuations from triggering liquidation.

The two methods have very different fee structures. A general comparison is provided below:

1. Buying CRVS through a traditional broker, such as Longbridge, Moomoo, Futu Securities, or IBKR

Trading commissions and platform fees: Many U.S. stock brokers now offer zero-commission trading, charging only a small platform fee of around $0.99–$1 per trade. Some brokers that do not charge platform fees have trading costs close to zero.

Cross-border funding and FX conversion costs (the main cost): For users outside the U.S. who fund their accounts in local currency to buy U.S. stocks, bank wire transfer fees and FX spreads of around 0.5%–1.5% can represent the main hidden costs.

Regulatory fees: Stock sales may incur small SEC regulatory fees and FINRA trading activity fees, typically amounting to only a few cents per trade and having minimal impact on overall costs.

2. Buying rCRVS, issued by Reality, on the crypto exchange Bitget (trading pair: rCRVS/USDT)

Transaction fees: Standard crypto exchange spot transaction fees apply, with base rates typically around 0.05%–0.1%. Fees may be reduced further by holding a platform token such as BGB or reaching a higher VIP level.

No fiat FX conversion costs: You can trade directly using USDT held in your account, avoiding the fiat FX conversion and cross-border wire transfer costs typically associated with traditional finance.

No SEC fees: As the transaction involves an on-chain token rather than a directly cleared U.S. stock trade, the related regulatory fees do not apply.

Recommendations by scenario:

If you hold crypto such as USDT, buying on a crypto exchange may be more cost-effective. Converting USDT into USD cash and then buying CRVS through a traditional broker may incur P2P conversion costs, bank deposit and withdrawal fees, and FX fees, with combined costs typically around 1%–2% or more. By comparison, buying rCRVS directly on a crypto exchange may incur only a transaction fee of around 0.05%–0.1%.

If you hold non-USD cash, buying on a crypto exchange may also be more cost-effective. Converting non-USD cash into USD and then buying CRVS through a traditional broker may involve FX spreads, wire transfer fees, and broker platform fees or commissions, with combined costs typically around 0.5%–2% or more. Buying rCRVS directly on a crypto exchange avoids fiat FX conversion and cross-border wire transfers, leaving only a spot transaction fee of around 0.05%–0.1%. This may offer greater cost and capital efficiency.

If you hold USD cash, buying through a traditional U.S. broker may be more cost-effective. Funding a brokerage account directly in USD can provide access to zero-commission or very low-cost trading. Converting USD into USDT first to buy rCRVS may instead introduce an additional funding cost.

在加密貨幣與美股 RWA 結合的生態中，支援使用 USDT 直接交易 CRVS 代幣化股票的平台主要集中在前沿的加密貨幣全景交易所（UEX）。Bitget 是目前該領域最具代表性且交易量領先的平台之一。

Bitget 2026 年 6 月份在業界率先推出了全網領先的新一代代幣化股票產品 —— Bitget rToken，Bitget rToken 允許用戶直接使用主流穩定幣（如 USDT）在現貨市場交易美股熱門標的（包含 CRVS）。

Bitget rToken 直通華爾街深度，享受真實派息，支援合約保證金！

在 Bitget 股票現貨市場購買 CRVS 代幣化股票的簡短步驟：

1. 註冊與完成身分認證：登入 Bitget 帳戶並完成基礎身分認證。

2. 準備 USDT：確保現貨/資金帳戶中持有 USDT。

3. 進入股票專區：在平台內找到股票專區，搜尋「rCRVS」。

4. 下單交易：輸入您想投入的 USDT 金額或代幣數量，選擇市價或限價單即可完成購買。

Bitget rToken 支援美股的碎股交易。

透過 Bitget 的 rToken 功能，用戶可以直接使用加密貨幣（如穩定幣 USDT ）來購買包括 CRVS 在內的美股整股與碎股。代幣化股票由於其區塊鏈可分割的特性，天然支援極小比例的分割。用戶可以隨意以幾美元的 USDT 買入遠小於 1 股的 CRVS 份額。

在 Bitget 購買美股碎股的特性：

1. 直連加密貨幣：無需繁瑣的傳統離岸銀行電匯，可直接用 USDT 參與美股。

2. 權益支援：持有的 rToken 享有對應標的資產的經濟權益（如現金股利派發）。

3. 合規與清算：底層交易與結算由持牌金融機構支援（如 Reality、Alpaca）。

4. 地理限制提醒：該功能對部分國家和地區（如美國、英國、歐盟、新加坡、香港等）有限制，具體可參考 Bitget 平台目前的合規准入條款。

rCRVS 是新上線的 Bitget rToken 的其中一支，是發行方 Reality 錨定 CRVS 股票發行的代幣化股票。

rCRVS 具有以下特性：1:1 錨定真實美股 CRVS，可 7×24 小時交易，支援碎股，享有股利分紅，且可作為平台統一帳戶和 U 本位合約保證金。

這意味著，如果您沒有美股帳戶，您可以透過加密貨幣（如 USDT）去購買 rCRVS，不僅可以持有 CRVS 股票，還可享有 CRVS 的股利分紅。

交易 rCRVS 和交易 BTC 等加密貨幣的體驗完全一致，同時平台也支援透過美股直連直接購買 CRVS 股票。

rCRVS 的核心運行機制：

1. USDT 直接計價與交易：無需將資金兌換成傳統美元或透過離岸電匯，用戶可以直接用錢包或帳戶裡的 USDT 購買和出售 CRVS 代幣化股票（通常顯示為 rCRVS）。

2. 天然支援碎股：代幣化股票由於其區塊鏈可分割的特性，天然支援極小比例的分割。用戶可以輕鬆以幾美元的 USDT 買入遠小於 1 股的 CRVS 份額。

3. 1:1 經濟映射與分紅：該板塊資產由合規的 RWA 發行商（如 Reality 等）支援，實現 1:1 的底層資產經濟權益映射。美股上市公司發放現金股利時，Bitget 會自動將其轉換為 USDT 並派發到用戶帳戶中。

4. 生態深度融合：在 Bitget 的「全景交易所（UEX）」架構下，持有的 CRVS 代幣化股票不僅能進行現貨交易，還可以部分接入統一帳戶、槓桿、網格機器人或衍生品生態中。

rCRVS 的推出和運作是由多方協作完成的：

rCRVS 發行商：Reality Protocol —— Bitget 旗下持牌 RWA 協議。Reality Protocol 負責 RWA 股票代幣的鏈上發行，以及對應底層股票資產的託管，確保代幣與實際持倉一一對應。

股票託管券商：Alpaca Securities —— 在美國 FINRA 註冊、受 SIPC 保護的合規券商。Alpaca Securities 負責託管所有 RWA 代幣對應的底層股票資產，確保每枚代幣背後都有真實持倉支撐。

資產證明：The Network Firm —— 獨立的第三方機構。The Network Firm 對 Reality 託管的底層股票持倉進行獨立驗證，提供可靠背書。

交易與流通平台：Bitget 交易所作為主要的現貨和衍生性商品交易市場，為用戶提供直接使用 USDT 交易 rCRVS 的流動性支援。

rCRVS 運行在 Arbitrum 鏈上，用戶可以透過支援該網路的錢包或 Bitget 統一帳戶進行鏈上與鏈下的資產互動。

rCRVS 資產設計上主打底層 1:1 真實的 CRVS 股票支撐。

根據 Reality 協議官方公布的運作機制，當用戶在 Bitget 平台購買 rCRVS 時，發行方會透過合規的底層持牌券商（如 Alpaca Securities 等）在美股市場上實際買入並持有相應數量的真實 CRVS 股票。

rCRVS 同時實現 1:1 的底層資產經濟權益映射。這意味著 rCRVS 的價格走勢、公司分紅（如現金股利會自動折算為穩定幣派發）以及拆股等公司行為，都會與真實美股市場 CRVS 的價格和公司行動保持同步。

rCRVS 實現了從資產到公司行動的 100% 完美鏡像映射：

現金股利直達：股票現金分紅自動折算為 USDT 直接發放至您的帳戶，時間、金額一目了然。

股票股利直發：以代幣形式 1:1 即時增發至帳戶，持倉成本與資產總額即時更新。

拆股併股零時差：股票分割與合併即時對應至鏈上代幣，確保您的持股比例與美股市場完全同步，徹底告別脫錨風險。

rCRVS 的即時價格為 $10.59。為了獲得最準確的最新價格數據，您可以直接查看本頁面頂部，該區域提供 24 小時即時更新的核心指標，包括：目前最新價格、24 小時漲跌幅、歷史價格走勢圖、市盈率、股息收益率、股息金額等相關股票數據。同時，您也可以向下捲動查看更多關於今日 rCRVS 價格分析內容，您也可以點選【交易】按鈕進入交易頁面，查看更詳細的即時買賣盤口與深度圖表。

您可以在 Bitget 使用符合資格的代幣化股票（rToken）作為合約交易的保證金。

Bitget 推出了跨資產統一帳戶（UTA）及多元資產保證金模式，讓用戶可以將特定主流美股和 ETF 的代幣化資產（如關聯蘋果、特斯拉、輝達、微軟、亞馬遜、SPY、QQQ 等數百種資產的代幣）納入統一的保證金池中。

核心要點說明：

多重資產抵押：在開啟對應的統一帳戶或多資產保證金模式後，這些代幣化股票不僅能為您提供對應的資產價格敞口，還可以作為保證金來支援其他衍生品或合約交易（如 U 本位合約）。

提升資金效率：無需單獨將代幣化資產變現或兌換成穩定幣，您可以直接利用它們來優化整體投資組合的資金利用率。

風險警示：將代幣化資產作為抵押品會增加帳戶的整體槓桿率。如果相關代幣化股票價格下跌，可能會觸發追加保證金（Margin Call）或強制平倉風險，請務必注意管理好倉位風險。